alexa Gastric Carcinoid|OMICS International|Journal Of Neurology And Neurophysiology

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Gastric Carcinoid

Gastric Neuroendocrine Tumors (NETs), formerly known as Gastric Carcinoids (GCs), are neoplasms derived from enterochromaffin cells of the stomach. This heterogeneous group of tumors has been historically divided into three types, best distinguished by etiology. Type I gastric carcinoids, comprising 70-80% of gastric neuroendocrine tumors, are associated with autoimmune chronic atrophic gastritis. As a result of this condition, widespread parietal cell loss leads to chronic achlorhydria, causing G cell hypersecretion of gastrin. Type II gastric carcinoids, accounting for 5-8% of gastric are associated with gastrinomas and Zollinger-Ellison Syndrome. Neoplastic G cells secrete gastrin, again resulting in hypergastrinemia. In both Types I and II gastric carcinoids,exorbitant levels of gastrin lead to hyperplasia, dysplasia and ultimately neoplastic changes in the stomach. Type III gastric carcinoids,constituting 15-25% of gastric NETs, are sporadic in nature, without associated increases in gastrin levels. The pathophysiology of Type III gastric carcinoids remains to be elucidated.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on July, 2014